Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2019
Mar. 31, 2018
CURRENT ASSETS    
Cash $ 3,828,074 $ 6,974,070
Accounts receivable 0 74,813
Prepaid expenses and other current assets 210,042 181,367
TOTAL CURRENT ASSETS 4,038,116 7,230,250
Property and equipment, net 6,021 27,552
Patents, net 66,668 75,832
Deposits 12,159 18,270
TOTAL ASSETS 4,122,964 7,351,904
CURRENT LIABILITIES    
Accounts payable 131,931 124,450
Due to related parties 83,654 90,366
Convertible notes payable, net 962,301 0
Other current liabilities 646,000 263,141
TOTAL CURRENT LIABILITIES 1,823,886 477,957
Convertible notes payable, net 0 841,153
TOTAL LIABILITIES 1,823,886 1,319,110
COMMITMENTS AND CONTINGENCIES (Note 12)
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value, 30,000,000 shares authorized at March 31, 2019 and 2018; 19,004,253 and 17,739,511 issued and outstanding at March 31, 2019 and 2018, respectively 19,004 17,740
Additional paid-in capital 108,058,538 105,574,014
Accumulated deficit (105,652,433) (99,457,714)
TOTAL AETHLON MEDICAL, INC. STOCKHOLDERS' EQUITY BEFORE NONCONTROLLING INTERESTS 2,425,109 6,134,040
NONCONTROLLING INTERESTS (126,031) (101,246)
TOTAL STOCKHOLDERS' EQUITY 2,299,078 6,032,794
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 4,122,964 $ 7,351,904